Covered recipient · General Payments record

PETER RUSSELL KOWEY

Allopathic & Osteopathic Physicians Internal Medicine Cardiovascular Disease

NPI: 1114922945
CMS profile: 277648
Location: WYNNEWOOD, PA

General Payments · PY2018–2024

$1,612,188.24

Reported across 528 records
CMS publication 2026-01-23

Latest program year · PY2024

$200,403.65

73 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated

The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of payment	Amount	Records
Consulting Fee	$199,666.25	71
Travel and Lodging	$587.40	1
Food and Beverage	$150.00	1

By paying entity

PY2024 · sorted by reported total

Paying entity	Amount	Records
E.R. Squibb & Sons, L.L.C.	$47,100.00	5
Janssen Research & Development, LLC	$39,640.00	13
GlaxoSmithKline, LLC.	$28,350.00	7
Moderna TX, Inc.	$17,715.00	20
Novo Nordisk AS	$12,943.65	3
Bausch Health US, LLC	$10,800.00	2
Acerta Pharma LLC	$10,075.00	1
ABBVIE INC.	$8,450.00	8
UCB SA	$7,800.00	4
AstraZeneca UK Limited	$6,600.00	5
SANOFI US SERVICES INC.	$4,270.00	1
Mirum Pharmaceuticals, Inc.	$2,925.00	1
Takeda Pharmaceuticals U.S.A., Inc.	$2,100.00	2
Merck Sharp & Dohme Corporation	$1,635.00	1

By program year

All program years on this page · sorted by year

Program year	Amount	Records
PY2018	$296,163.19	125
PY2019	$297,335.37	94
PY2020	$182,648.69	54
PY2021	$221,354.76	62
PY2022	$228,808.50	63
PY2023	$185,474.08	57
PY2024	$200,403.65	73

Payment records · PY2024 (73)

Sorted by paying entity, then date · as published by CMS

Program year 2024 2018 2019 2020 2021 2022 2023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.

Paying entity	Amount	Date	Nature of payment	Dispute status	Published	Record ID	Source
ABBVIE INC.	$975.00	01/05/2024	Consulting Fee	Undisputed	01/23/2026	1103136433	CMS
ABBVIE INC.	$325.00	01/25/2024	Consulting Fee	Undisputed	01/23/2026	1103136435	CMS
ABBVIE INC.	$325.00	02/28/2024	Consulting Fee	Undisputed	01/23/2026	1103136437	CMS
ABBVIE INC.	$325.00	03/22/2024	Consulting Fee	Undisputed	01/23/2026	1103136439	CMS
ABBVIE INC.	$1,625.00	04/24/2024	Consulting Fee	Undisputed	01/23/2026	1103136441	CMS
ABBVIE INC.	$1,625.00	07/26/2024	Consulting Fee	Undisputed	01/23/2026	1103136443	CMS
ABBVIE INC.	$1,950.00	08/29/2024	Consulting Fee	Undisputed	01/23/2026	1103136445	CMS
ABBVIE INC.	$1,300.00	10/22/2024	Consulting Fee	Undisputed	01/23/2026	1103136447	CMS
AstraZeneca Pharmaceuticals LP	$10,075.00	06/11/2024	Consulting Fee	Undisputed	01/23/2026	1110542883	CMS
AstraZeneca UK Limited	$900.00	04/18/2024	Consulting Fee	Undisputed	01/23/2026	1110552578	CMS
AstraZeneca UK Limited	$1,800.00	07/16/2024	Consulting Fee	Undisputed	01/23/2026	1110550522	CMS
AstraZeneca UK Limited	$600.00	09/05/2024	Consulting Fee	Undisputed	01/23/2026	1110541385	CMS
AstraZeneca UK Limited	$2,700.00	09/12/2024	Consulting Fee	Undisputed	01/23/2026	1110548390	CMS
AstraZeneca UK Limited	$600.00	11/07/2024	Consulting Fee	Undisputed	01/23/2026	1110530953	CMS
Bausch Health US, LLC	$6,750.00	05/22/2024	Consulting Fee	Undisputed	01/23/2026	1148023135	CMS
Bausch Health US, LLC	$4,050.00	07/10/2024	Consulting Fee	Undisputed	01/23/2026	1148023133	CMS
E.R. Squibb & Sons, L.L.C.	$15,900.00	04/26/2024	Consulting Fee	Undisputed	01/23/2026	1101425874	CMS
E.R. Squibb & Sons, L.L.C.	$4,800.00	06/10/2024	Consulting Fee	Undisputed	01/23/2026	1101425884	CMS
E.R. Squibb & Sons, L.L.C.	$6,600.00	08/06/2024	Consulting Fee	Undisputed	01/23/2026	1101425900	CMS
E.R. Squibb & Sons, L.L.C.	$12,000.00	09/25/2024	Consulting Fee	Undisputed	01/23/2026	1101425938	CMS
E.R. Squibb & Sons, L.L.C.	$7,800.00	12/19/2024	Consulting Fee	Undisputed	01/23/2026	1101425932	CMS
GlaxoSmithKline, LLC.	$1,750.00	03/11/2024	Consulting Fee	Undisputed	01/23/2026	1116164180	CMS
GlaxoSmithKline, LLC.	$2,750.00	03/26/2024	Consulting Fee	Undisputed	01/23/2026	1116529562	CMS
GlaxoSmithKline, LLC.	$2,500.00	05/20/2024	Consulting Fee	Undisputed	01/23/2026	1115895122	CMS
GlaxoSmithKline, LLC.	$5,500.00	08/05/2024	Consulting Fee	Undisputed	01/23/2026	1116339942	CMS
GlaxoSmithKline, LLC.	$1,500.00	09/23/2024	Consulting Fee	Undisputed	01/23/2026	1116663643	CMS
GlaxoSmithKline, LLC.	$4,750.00	10/29/2024	Consulting Fee	Undisputed	01/23/2026	1116181005	CMS
GlaxoSmithKline, LLC.	$9,600.00	11/27/2024	Consulting Fee	Undisputed	01/23/2026	1115977627	CMS
Janssen Research & Development, LLC	$2,790.00	01/11/2024	Consulting Fee	Undisputed	01/23/2026	1077589813	CMS
Janssen Research & Development, LLC	$1,800.00	01/19/2024	Consulting Fee	Undisputed	01/23/2026	1077589805	CMS
Janssen Research & Development, LLC	$4,340.00	02/16/2024	Consulting Fee	Undisputed	01/23/2026	1077589821	CMS
Janssen Research & Development, LLC	$4,960.00	04/08/2024	Consulting Fee	Undisputed	01/23/2026	1077589817	CMS
Janssen Research & Development, LLC	$2,400.00	04/29/2024	Consulting Fee	Undisputed	01/23/2026	1077589827	CMS
Janssen Research & Development, LLC	$1,000.00	06/13/2024	Consulting Fee	Undisputed	01/23/2026	1077589807	CMS
Janssen Research & Development, LLC	$2,000.00	06/14/2024	Consulting Fee	Undisputed	01/23/2026	1077589815	CMS
Janssen Research & Development, LLC	$1,500.00	07/11/2024	Consulting Fee	Undisputed	01/23/2026	1077589819	CMS
Janssen Research & Development, LLC	$7,130.00	07/11/2024	Consulting Fee	Undisputed	01/23/2026	1077589825	CMS
Janssen Research & Development, LLC	$600.00	07/29/2024	Consulting Fee	Undisputed	01/23/2026	1077589823	CMS
Janssen Research & Development, LLC	$6,820.00	10/01/2024	Consulting Fee	Undisputed	01/23/2026	1077589809	CMS
Janssen Research & Development, LLC	$1,200.00	11/11/2024	Consulting Fee	Undisputed	01/23/2026	1077589811	CMS
Janssen Research & Development, LLC	$3,100.00	12/23/2024	Consulting Fee	Undisputed	01/23/2026	1077589803	CMS
Merck Sharp & Dohme LLC	$1,635.00	07/03/2024	Consulting Fee	Undisputed	01/23/2026	1141795452	CMS
Mirum Pharmaceuticals, Inc.	$2,925.00	04/03/2024	Consulting Fee	Undisputed	01/23/2026	1123324193	CMS
ModernaTX, Inc.	$650.00	02/28/2024	Consulting Fee	Undisputed	01/23/2026	1152554661	CMS
ModernaTX, Inc.	$1,300.00	02/28/2024	Consulting Fee	Undisputed	01/23/2026	1152554663	CMS
ModernaTX, Inc.	$2,925.00	02/28/2024	Consulting Fee	Undisputed	01/23/2026	1152554665	CMS
ModernaTX, Inc.	$325.00	03/20/2024	Consulting Fee	Undisputed	01/23/2026	1152554667	CMS
ModernaTX, Inc.	$325.00	03/20/2024	Consulting Fee	Undisputed	01/23/2026	1152554669	CMS
ModernaTX, Inc.	$325.00	03/20/2024	Consulting Fee	Undisputed	01/23/2026	1152554671	CMS
ModernaTX, Inc.	$975.00	03/20/2024	Consulting Fee	Undisputed	01/23/2026	1152554673	CMS
ModernaTX, Inc.	$2,600.00	03/20/2024	Consulting Fee	Undisputed	01/23/2026	1152554675	CMS
ModernaTX, Inc.	$650.00	04/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554677	CMS
ModernaTX, Inc.	$33.00	04/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554679	CMS
ModernaTX, Inc.	$33.00	04/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554681	CMS
ModernaTX, Inc.	$33.00	04/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554683	CMS
ModernaTX, Inc.	$66.00	04/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554685	CMS
ModernaTX, Inc.	$325.00	07/01/2024	Consulting Fee	Undisputed	01/23/2026	1152554687	CMS
ModernaTX, Inc.	$650.00	07/01/2024	Consulting Fee	Undisputed	01/23/2026	1152554689	CMS
ModernaTX, Inc.	$650.00	09/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554713	CMS
ModernaTX, Inc.	$975.00	09/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554715	CMS
ModernaTX, Inc.	$3,250.00	09/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554717	CMS
ModernaTX, Inc.	$1,300.00	09/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554719	CMS
ModernaTX, Inc.	$325.00	09/03/2024	Consulting Fee	Undisputed	01/23/2026	1152554721	CMS
Novo Nordisk Inc	$150.00	05/07/2024	Food and Beverage	Undisputed	01/23/2026	1096620148	CMS
Novo Nordisk Inc	$12,206.25	05/07/2024	Consulting Fee	Undisputed	01/23/2026	1097322846	CMS
Novo Nordisk Inc	$587.40	05/07/2024	Travel and Lodging	Undisputed	01/23/2026	1097838483	CMS
SANOFI US SERVICES INC.	$4,270.00	02/14/2024	Consulting Fee	Undisputed	01/23/2026	1139842209	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$900.00	01/15/2024	Consulting Fee	Undisputed	01/23/2026	1137607699	CMS
Takeda Pharmaceuticals U.S.A., Inc.	$1,200.00	11/04/2024	Consulting Fee	Undisputed	01/23/2026	1144961092	CMS
UCB SA	$2,100.00	02/02/2024	Consulting Fee	Undisputed	01/23/2026	1113950969	CMS
UCB SA	$2,700.00	05/03/2024	Consulting Fee	Undisputed	01/23/2026	1113950971	CMS
UCB SA	$1,500.00	12/13/2024	Consulting Fee	Undisputed	01/23/2026	1113950965	CMS
UCB SA	$1,500.00	12/13/2024	Consulting Fee	Undisputed	01/23/2026	1113950967	CMS

Source & provenance

Dataset: CMS Open Payments — General Payments
Publisher of source data: Centers for Medicare & Medicaid Services
CMS publication date: 2026-01-23
Program years on this page: 2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files: Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.